EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,236,468 | -53.3% | 1,246,020 | +0.9% | 0.02% | -51.9% |
| Q2 2023 | $9,073,185 | -29.6% | 1,234,447 | -0.8% | 0.05% | -34.2% |
| Q1 2023 | $12,885,582 | -12.9% | 1,243,782 | -0.7% | 0.08% | -21.0% |
| Q4 2022 | $14,798,427 | -27.2% | 1,253,042 | +29.4% | 0.10% | -37.9% |
| Q3 2022 | $20,329,000 | -39.7% | 968,506 | -10.8% | 0.16% | -38.3% |
| Q2 2022 | $33,706,000 | +63.1% | 1,085,874 | +115.8% | 0.26% | +87.8% |
| Q1 2022 | $20,665,000 | +8003.9% | 503,288 | +12871.3% | 0.14% | +3375.0% |
| Q3 2018 | $255,000 | -11.1% | 3,880 | -31.7% | 0.00% | -20.0% |
| Q2 2018 | $287,000 | -70.8% | 5,680 | -69.6% | 0.01% | -68.8% |
| Q1 2018 | $984,000 | -88.7% | 18,680 | -90.0% | 0.02% | -89.5% |
| Q4 2017 | $8,701,000 | +30.8% | 187,233 | +13.9% | 0.15% | +18.6% |
| Q3 2017 | $6,650,000 | +30.0% | 164,403 | +9.0% | 0.13% | +18.3% |
| Q2 2017 | $5,116,000 | +16.9% | 150,873 | +0.1% | 0.11% | +23.9% |
| Q1 2017 | $4,377,000 | +26.3% | 150,713 | +42.8% | 0.09% | +31.3% |
| Q4 2016 | $3,466,000 | +61.7% | 105,553 | +55.2% | 0.07% | +76.3% |
| Q3 2016 | $2,144,000 | -20.5% | 68,013 | -29.1% | 0.04% | -32.1% |
| Q2 2016 | $2,697,000 | +27.6% | 95,915 | +65.0% | 0.06% | +24.4% |
| Q1 2016 | $2,113,000 | -9.2% | 58,133 | 0.0% | 0.04% | -2.2% |
| Q4 2015 | $2,326,000 | +38.6% | 58,133 | -1.3% | 0.05% | +35.3% |
| Q3 2015 | $1,678,000 | -52.0% | 58,903 | -44.5% | 0.03% | -48.5% |
| Q2 2015 | $3,495,000 | +11.9% | 106,073 | -2.3% | 0.07% | +24.5% |
| Q1 2015 | $3,122,000 | -3.9% | 108,543 | -9.0% | 0.05% | -5.4% |
| Q4 2014 | $3,250,000 | +7.5% | 119,343 | -15.8% | 0.06% | +12.0% |
| Q3 2014 | $3,022,000 | -16.6% | 141,803 | -12.1% | 0.05% | -16.7% |
| Q2 2014 | $3,622,000 | -21.3% | 161,243 | -11.5% | 0.06% | -22.1% |
| Q1 2014 | $4,605,000 | +5.6% | 182,243 | -4.0% | 0.08% | +16.7% |
| Q4 2013 | $4,362,000 | +19.1% | 189,753 | -1.4% | 0.07% | +6.5% |
| Q3 2013 | $3,664,000 | +2.3% | 192,353 | -22.5% | 0.06% | -1.6% |
| Q2 2013 | $3,581,000 | – | 248,303 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |